Abstract: The present invention provides a novel method that can increase readily a virus or viral vector concentration in a solution having a low concentration and a kit for performing the method. Conventional methods require complicated operations, expensive equipment, or highly trained experts for efficiently concentrating viruses from low-concentration virus solutions. The method of the present invention can concentrate viral vectors readily while maintaining infection abilities of the viral vectors, and thus it can be used as a safe and simple technique for concentrating a vector useful in the field of a genetic therapy or a vaccine therapy using a viral vector.
Type:
Application
Filed:
March 31, 2009
Publication date:
March 3, 2011
Applicants:
Japan Tobacco Inc., Virus Ikagaku Kenkyusho Inc.
Abstract: A peptide is disclosed for detection of a herpe4s virus infection in an animal subject susceptible thereto, wherein the peptide comprises a compound of the Formula: ##STR1## designated Sequence ID 1.
Type:
Grant
Filed:
September 5, 1996
Date of Patent:
June 2, 1998
Assignee:
Bio-Virus Research Incorporated
Inventors:
Daniel B. Golubev, Alexander Chaihorsky
Abstract: A pharmaceutical composition is disclosed for the treatment against several herpes virus infections or atherosclerotic plaques in a mammalian subject suspectible thereto which comprises: (a) 10 to 30% by weight of the peptide of SEQ ID 2; (b) 10 to 30% by weight of the peptide of SEQ ID 4; 10 to 30% by weight of the peptide of SEQ ID 6; and (d) 10 to 30% by weight of the peptide of SEQ ID 8; in combination with a pharmaceutically acceptable inert carrier.
Abstract: A composition is disclosed for generating an immune response against a herpes virus in an animal subject susceptible thereto, wherein the vaccine comprises a compound of the Formula:Val Asn Pro Arg Gly Gly Cys Phe Leu Gly Gly Gly Ala Lys Ala Gly 5 10 - 15 Gly Gly Gly Gly Arg Ala Ala Gly Gln Pro Arg Ala 20 25designated Sequence ID 1. The composition is especially effective in generating an immune response against Kaposi's sarcoma herpesvirus.
Type:
Grant
Filed:
June 1, 1998
Date of Patent:
January 18, 2000
Assignee:
Bio-Virus Research Incorporated
Inventors:
Daniel B. Golubev, Alexander Chaihorsky
Abstract: It is intended to provide a virus vector by which an exogenous nucleotide sequence can be inserted and easily transferred into a mammalian host cell and a gene encoded by the exogenous nucleotide sequence can be expressed in the host cell, and which has a low risk of pathogenicity and is appropriately usable in gene therapy of mammals. Namely, a recombinant vector originating in HHV-6 which has an exogenous nucleotide sequence in a portion corresponding to at least one region selected from the group consisting of U2, U3, U4, U5, U6, U7, U8, U24, and U25 regions of HHV-6; or a recombinant vector originating in HHV-7 which has an exogenous nucleotide sequence in a portion corresponding to at least one region selected from the group consisting of U2, U3, U4, U7, U8, U24, U24a, and U25 regions of HHV-7.
Abstract: It is intended to provide a virus vector by which an exogenous nucleotide sequence can be inserted and easily transferred into a mammalian host cell and a gene encoded by the exogenous nucleotide sequence can be expressed in the host cell, and which has a low risk of pathogenicity and is appropriately usable in gene therapy of mammals. Namely, a recombinant vector originating in HHV-6 which has an exogenous nucleotide sequence in a portion corresponding to at least one region selected from the group consisting of U2, U3, U4, U5, U6, U7, U8, U24, and U25 regions of HHV-6; or a recombinant vector originating in HHV-7 which has an exogenous nucleotide sequence in a portion corresponding to at least one region selected from the group consisting of U2, U3, U4, U7, U8, U24, U24a, and U25 regions of HHV-7.
Abstract: A system and method for efficiently managing computer virus definitions using a structured virus database are described. One or more virus definition records are stored in a structured virus database. Each virus definition record includes an identifier uniquely identifying a computer virus, at least one virus name associated with the computer virus, a virus definition sentence including object code providing operations to detect the identified computer virus within a computer system, and a virus removal sentence including object code providing operations to clean the identified computer virus from the computer system. The virus definition records in the structured virus database are accessed indexed by the identifier and the at least one virus name for each virus definition record. The object code of the virus definition sentence and the virus removal sentence for each accessed virus definition record is interpreted.
Abstract: A system and method for distributing portable computer virus definition records with binary file conversion are described. One or more virus definition records are stored into a structured virus database. Each virus definition record includes an identifier uniquely identifying a computer virus, at least one virus name associated with the computer virus, a virus definition sentence comprising object code providing operations to detect the identified computer virus within a computer system, and a virus removal sentence comprising object code providing operations to clean the identified computer virus from the computer system. At least one updated virus definition record is stored into the structured virus database indexed by the identifier and the at least one virus name for each virus definition record. The virus definition records stored in the structured virus database are converted into a virus data file. The virus data file includes virus definition sets.
Abstract: A method for replication of hepatitis C virus genome comprising infecting animal cells that have been infected with mouse retrovirus, with hepatitis C virus, and then culturing those cells. The present invention further provides a method for distinguishing a hepatitis C virus with high infectivity and a hepatitis C virus with less infectivity, comprising centrifugating a sample comprising a virus to be tested in a liquid medium to determine the density of the virus, and assigning the virus to a hepatitis C virus with high infectivity it the density thereof is up to about 1.06 g/ml, and assigning the virus to a hepatitis C virus with less infectivity if the density thereof is at least 1.
Abstract: A method for replication of hepatitis C virus genome comprising infecting animal cells that have been infected with mouse retrovirus, with hepatitis C virus, and then culturing those cells. The present invention further provides a method for distinguishing a hepatitis C virus with high infectivity and a hepatitis C virus with less infectivity, comprising centrifugating a sample comprising a virus to be tested in a liquid medium to determine the density of the virus, and assigning the virus to a hepatitis C virus with high infectivity if the density thereof is up to about 1.06 g/ml, and assigning the virus to a hepatitis C virus with less infectivity if the density thereof is at least 1.
Abstract: A method and a device for searching for a parent virus file are disclosed. The method includes: determining an arbitrary virus file as a child virus file; obtaining a computer containing the child virus file; identifying a time when the child virus file first appeared in the computer; identifying times when other virus files contained in the computer that are different from the child virus file are first executed; determining suspect parent virus files from among the other virus files, the suspect parent virus files being first executed within a predetermined time period before the time when the child virus file first appeared in the computer; and determining the parent virus file from among the suspect parent virus files. Based on a principle that the time when the parent virus file is first executed is earlier that the time when the child virus file first appears, the suspect parent virus files are determined, and the parent virus file is found from among the suspect parent virus files.
Abstract: A method and a device for obtaining virus signatures in the field of computer security have been disclosed. The method includes: obtaining text strings contained in each virus sample within a virus sample set; selecting text strings for use as virus signatures candidate according to a first frequency at which each text string occurs in a non-virus sample set and a second frequency at which each text string occurs in the virus sample set; calculating an information entropy of the virus signatures candidate according to a quantity of virus samples containing the virus signatures candidate and a quantity of non-virus samples containing the virus signatures candidate; and selecting virus signatures from the virus signatures candidate according to the information entropy. The present disclosure may timely identify the latest virus signatures and ensure that the obtained virus signatures are optimal signatures and may identify a wide range of virus variants.
Abstract: Disclosed are methods of treating, inhibiting, or preventing a viral infection in a mammal in need thereof by administering a therapeutically or prophylactically effective amount of an inhibitor of FAP, an inhibitor of DPPIV, an inhibitor of DPP8, or an inhibitor of DPP9. The inhibitor may act as both an inhibitor of DPPIV and an inhibitor of DPP8/9. The viral infection includes, but is not limited to, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, Polio virus, Coxsackie A virus, Coxsackie B virus, Rhino virus, respiratory syncytial virus, dengue virus, equine infectious anemia virus, Echo virus, small pox virus, Ebola virus, and West Nile virus.
Abstract: A method and a device for obtaining virus signatures in the field of computer security have been disclosed. The method includes: obtaining text strings contained in each virus sample within a virus sample set; selecting text strings for use as virus signatures candidate according to a first frequency at which each text string occurs in a non-virus sample set and a second frequency at which each text string occurs in the virus sample set; calculating an information entropy of the virus signatures candidate according to a quantity of virus samples containing the virus signatures candidate and a quantity of non-virus samples containing the virus signatures candidate; and selecting virus signatures from the virus signatures candidate according to the information entropy. The present disclosure may timely identify the latest virus signatures and ensure that the obtained virus signatures are optimal signatures and may identify a wide range of virus variants.
Abstract: A method and a device for obtaining virus signatures in the field of computer security have been disclosed. The method includes: obtaining text strings contained in each virus sample within a virus sample set; selecting text strings for use as virus signatures candidate according to a first frequency at which each text string occurs in a non-virus sample set and a second frequency at which each text string occurs in the virus sample set; calculating an information entropy of the virus signatures candidate according to a quantity of virus samples containing the virus signatures candidate and a quantity of non-virus samples containing the virus signatures candidate; and selecting virus signatures from the virus signatures candidate according to the information entropy. The present disclosure may timely identify the latest virus signatures and ensure that the obtained virus signatures are optimal signatures and may identify a wide range of virus variants.
Abstract: A method and a device for obtaining virus signatures in the field of computer security have been disclosed. The method includes: obtaining text strings contained in each virus sample within a virus sample set; selecting text strings for use as virus signatures candidate according to a first frequency at which each text string occurs in a non-virus sample set and a second frequency at which each text string occurs in the virus sample set; calculating an information entropy of the virus signatures candidate according to a quantity of virus samples containing the virus signatures candidate and a quantity of non-virus samples containing the virus signatures candidate; and selecting virus signatures from the virus signatures candidate according to the information entropy. The present disclosure may timely identify the latest virus signatures and ensure that the obtained virus signatures are optimal signatures and may identify a wide range of virus variants.
Abstract: The present invention is directed to computer viruses and more particularly to a method and system for use in a virus-free certificate firewall, of controlling and filtering files using a virus-free certificate.
Type:
Application
Filed:
January 2, 2001
Publication date:
February 7, 2002
Inventors:
Jean-Francois Le Pennec, Olivier Hericourt
Abstract: The present invention is directed to computer viruses and more particularly to a method and system for use in a virus-free certificate firewall, of controlling and filtering files using a virus-free certificate.
Type:
Grant
Filed:
January 2, 2001
Date of Patent:
January 10, 2006
Assignee:
International Business Machines Corporation
Inventors:
Jean-Francois Le Pennec, Olivier Hericourt